Count me in!

Sequencing and Stratification of Systemic Therapy in HCC Symposium

Participate in the symposium in two different formats:
On-demand symposium from Monday, September 7th
LIVE Q&A session on Saturday, September 12, 2020: 4:20 PM – 4:35 PM CEST


Lorenza Rimassa, Deputy Director Medical Oncology Unit Humanitas Cancer Center Humanitas Research Hospital – IRCCS, Milan, Italy

R.Kate Kelley, Associate Professor of Clinical Medicine in the Department of Medicine at the University of California, San Francisco (UCSF) and the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC), USA


Join us to discuss the rapidly expanding systemic treatment landscape for advanced HCC!

In this session, we have invited leading experts to present and discuss a variety of challenges, including:

  • The expanding role of systemic therapy across stages in HCC
  • How to approach sequencing the multiple systemic therapy agents and regimens now available
  • Systemic therapy for special populations
  • Evolving considerations for clinical trial endpoints
  • The role of biomarkers in systemic therapy for HCC
  • New molecular targets and agents for HCC

Browse the full Scientific Programme


Benefit from the ILCA 2020 Virtual Conference Educational Grant

If you are a student or a trainee in the liver cancer field, you can benefit from an Educational Grant to attend the ILCA 2020 Virtual Conference and receive 1-year free ILCA membership. Interested in this opportunity? Then send us an email!

Contact ILCA for the Educational Grant


#ILCA20Virtual has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 7 European CME credits (ECMEC®s).

Read more here